Last updated: 2026-10-07 09:03:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Veeva Systems Inc. (VEEV) operates in the SERVICES-PREPACKAGED SOFTWARE sector and is listed on NYSE. The stock is currently priced at $283.63, with a market capitalization of $45.89B and a P/E ratio of 45.23. Over the past 52 weeks, its price has ranged from $148.05 to $310.50. This page covers its latest market performance, valuation, price trends and company information.
$45.89B | |
$284.81 | |
$343.96 | |
$17.11 | |
$283.50 | |
259.00 | |
1.68M | |
45.23 | |
$310.50 | |
$148.05 | |
-- | |
-- |
Veeva Systems Inc. (VEEV) is trading at $283.63 in pre-market trading as of 2026-10-07 08:58:00, up 0.05% ($0.13) from the previous close of $283.50
Pre-market trading shows how investors are pricing VEEV before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Veeva Systems Inc. (VEEV) moved from $279.96 to $283.63, representing a gain of 1.31% ($3.67).
The stock traded between $272.54 and $291.40 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 1.25 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 83.5%
VEEV is currently trading at $283.63, placing it 83.5% of the way from its 52-week low of $148.05 to its 52-week high of $310.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
| Industry | SERVICES-PREPACKAGED SOFTWARE |
| Employees | 7928 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Veeva Systems Inc. (VEEV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.